Redx Pharma PLC (FRA:0RX)
€ 0.167 0 (0%) Market Cap: 64.96 Mil Enterprise Value: 64.48 Mil PE Ratio: 0 PB Ratio: 15.00 GF Score: 33/100

Redx Pharma PLC £25.5m Raise To Drive Forward Key Programmes Discussion Transcript

Dec 07, 2020 / NTS GMT
Unidentified Analyst

Hello, there. You're watching Proactive London. And joining us today, we have Lisa Anson here from Redx Pharma, the drug discovery and development company, focused on cancer and fibrosis. Hello to you, Lisa?

Lisa Mary Whewell Anson
Redx Pharma Plc - CEO & Executive Director

Hi, [Casey], nice to see you.

Questions & Answers

Unidentified Analyst

Nice to see you. It's our first introduction here at Proactive, so plenty to discuss. But first of all, you've had a massive week because you've had this conditional raising of GBP 25.5 million. So I guess the question has to be, what are the plans now?

Lisa Mary Whewell Anson
Redx Pharma Plc - CEO & Executive Director

Yes. It's a very exciting announcement for us, the conditional raise that we announced this week and also the open offer. So this puts us in a much stronger financial position, which allows us really to drive forward our 2 key programs, 1 of which is in the clinic, 1 of which about to go into

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot